Aurobindo Pharma consolidated net profit declines 0.74% in the March 2018 quarter

Sales rise 11.35% to Rs 3988.63 crore

Net profit of Aurobindo Pharma declined 0.74% to Rs 528.51 crore in the quarter ended March 2018 as against Rs 532.45 crore during the previous quarter ended March 2017. Sales rose 11.35% to Rs 3988.63 crore in the quarter ended March 2018 as against Rs 3582.13 crore during the previous quarter ended March 2017.

For the full year,net profit rose 5.28% to Rs 2423.18 crore in the year ended March 2018 as against Rs 2301.67 crore during the previous year ended March 2017. Sales rose 9.35% to Rs 16232.87 crore in the year ended March 2018 as against Rs 14844.79 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales3988.633582.13 11 16232.8714844.79 9 OPM %19.7620.13 -23.2423.13 - PBDT807.78749.42 8 3799.173488.47 9 PBT651.15649.37 0 3241.203060.84 6 NP528.51532.45 -1 2423.182301.67 5

Powered by Capital Market - Live News